Method for preparing foot-and-mouth disease antigen
A foot-and-mouth disease and antigen technology, applied in the field of genetic engineering, can solve the problems of high production cost, virus escape, short immune period, etc., and achieve the effects of low cost, reduced production cost and high safety.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Preparation of embodiment 1 foot-and-mouth disease antigen, purification and animal immunization experiment and virus challenge protection experiment
[0033] 1. Cloning and sequence analysis of P1-2A and 3C genes
[0034] 1.1 Obtaining the target gene
[0035] Primers were designed to amplify the FMD virus antigenic protein P1-2A gene and non-structural protein 3C gene by RT-PCR.
[0036] The amplification primers of the designed antigenic protein P1-2A gene and nonstructural protein 3C gene are,
[0037] Upstream of P1-2A: 5'-ATA GGATCC ACCATGGGAGCCGGGCAATCCAGCC-3',
[0038] BamH I restriction site
[0039] Downstream of P1-2A: 5'-CGC GAATTC TGACATGTCCTCCTGCATCTGGTTG-3'.
[0040] EcoR I restriction site
[0041] 3C upstream: 5'-GCG GAATTC AAGAAACCTGTCGCTTTGAAAGT-3'.
[0042] EcoR I restriction site
[0043] Downstream of 3C: 5'-ATA AGATCT CTACTCGTGGTGTGGTTCGGGAT-3'
[0044] Bgl II restriction site
Embodiment 2
[0099] Preparation of embodiment 2 foot-and-mouth disease antigen, purification and animal immunization experiment and virus challenge protection experiment
[0100] 1. Cloning and sequence analysis of the full-length ORF of foot-and-mouth disease virus
[0101]Primers were designed to amplify the full-length ORF of foot and mouth disease virus (SEQ ID NO: 3) by RT-PCR.
[0102] The designed amplification primers for amplifying the full-length ORF are,
[0103] ORF: 5'-GCG ACTAGT ACCATGGAATTCACACTTCACAACGGTGAG-3',
[0104] Spe I restriction site
[0105] ORF: 5'-ATA GCGGCCGC AGGGATTATGCGTCACCGCACAC-3'.
[0106] Not I restriction site
[0107] Total RNA was extracted from FMDV cell culture medium. The extracted total RNA was treated with Oligo(dT) 18 Under the action of AMV reverse transcriptase, the primers were reverse-transcribed at 42°C to prepare cDNA. The obtained cDNA was used as a template, and PCR amplification was carried out with specific primers.
[0108...
Embodiment 3
[0135] Preparation of embodiment 3 foot-and-mouth disease antigen, purification and animal immunization experiment and virus challenge protection experiment
[0136] 1. Cloning and sequence analysis of FMDV VP1 gene
[0137] Primers were designed to amplify the foot disease virus VP1 gene by RT-PCR.
[0138] The designed amplification primers for amplifying the VP1 gene are,
[0139] VP1 upstream: 5'-ATA GGATCC ACCATGGCCACCACTACCGGCGAGTCAG-3',
[0140] BamH I restriction site
[0141] Downstream of VP1: 5'-CGC GAATTC TTACACCATCTGCTTTCCAGGTGCAAT-3'.
[0142] EcoR I restriction site
[0143] Total RNA was extracted from FMDV cell culture medium. The extracted total RNA was treated with Oligo(dT) 18 Under the action of AMV reverse transcriptase, the primers were reverse-transcribed at 42°C to prepare cDNA. The obtained cDNA was used as a template, and PCR amplification was carried out with specific primers.
[0144] The PCR reaction system is as follows:
[0145] Tabl...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com